Page last updated: 2024-08-22

platinum and bortezomib

platinum has been researched along with bortezomib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertoni, F; Catapano, CV; Colombo, N; Del Conte, G; Gadducci, A; Hess, D; Katsaros, D; Mancari, R; Marsoni, S; Parma, G; Rinaldi, A; Scambia, G; Sessa, C; van de Velde, H; Vitali, A1
Cheng, Y; Wang, C; Wang, X; Zhang, Q1

Trials

1 trial(s) available for platinum and bortezomib

ArticleYear
An open-label phase 2 study of twice-weekly bortezomib and intermittent pegylated liposomal doxorubicin in patients with ovarian cancer failing platinum-containing regimens.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; CA-125 Antigen; Carcinoma, Papillary; Cystadenocarcinoma, Serous; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Platinum; Polyethylene Glycols; Prognosis; Pyrazines; Retrospective Studies; Salvage Therapy; Survival Rate; Young Adult

2012

Other Studies

1 other study(ies) available for platinum and bortezomib

ArticleYear
Near infrared light-responsive and injectable supramolecular hydrogels for on-demand drug delivery.
    Chemical communications (Cambridge, England), 2016, Jan-18, Volume: 52, Issue:5

    Topics: alpha-Cyclodextrins; Animals; Antineoplastic Agents; Bortezomib; Cell Line, Tumor; Cell Survival; Dendrimers; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Fever; Humans; Hydrogels; Infrared Rays; Macromolecular Substances; Metal Nanoparticles; Mice; NIH 3T3 Cells; Platinum; Polyethylene Glycols; Structure-Activity Relationship

2016